• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过选择性破坏 INTAC 磷酸酶活性快速诱导全基因组 RNA Pol II 高度磷酸化的方案。

Protocol for rapidly inducing genome-wide RNA Pol II hyperphosphorylation by selectively disrupting INTAC phosphatase activity.

机构信息

Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Medical Epigenetics, Shanghai Key Laboratory of Radiation Oncology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.

Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Medical Epigenetics, Shanghai Key Laboratory of Radiation Oncology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.

出版信息

STAR Protoc. 2023 Dec 15;4(4):102640. doi: 10.1016/j.xpro.2023.102640. Epub 2023 Oct 12.

DOI:10.1016/j.xpro.2023.102640
PMID:37831607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10589876/
Abstract

While several inhibitors targeting RNA polymerase II (Pol II) kinases have been applied for inhibiting RNA Pol II phosphorylation, there are few approaches for inducing RNA Pol II hyperphosphorylation. Here, we present a protocol for constructing the INTS8 degradation tag (dTAG) system combined with ectopic expression of N-terminally truncated INTS8 (INTS8-ΔN) in DLD-1 cells. We describe steps for INTS8-dTAG cell line construction, validation of knockin and degradation, and INTS8-ΔN rescue. We then detail validation of RNA Pol II phosphorylation upregulation. For complete details on the use and execution of this protocol, please refer to Hu et al. (2023)..

摘要

虽然已经有几种针对 RNA 聚合酶 II (Pol II) 激酶的抑制剂被用于抑制 RNA Pol II 的磷酸化,但诱导 RNA Pol II 过度磷酸化的方法却很少。在这里,我们介绍了一种构建 INTS8 降解标签 (dTAG) 系统的方案,该系统结合了在 DLD-1 细胞中外源性表达 N 端截断的 INTS8 (INTS8-ΔN)。我们描述了 INTS8-dTAG 细胞系构建、敲入和降解验证以及 INTS8-ΔN 挽救的步骤。然后,我们详细说明了 RNA Pol II 磷酸化上调的验证。有关该方案使用和执行的完整详细信息,请参阅 Hu 等人。(2023)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e04/10589876/7fdf4f1bade8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e04/10589876/81e95f964b3e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e04/10589876/c6324425faba/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e04/10589876/89022a00b3d3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e04/10589876/e49b39f49477/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e04/10589876/910820426ef4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e04/10589876/7fdf4f1bade8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e04/10589876/81e95f964b3e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e04/10589876/c6324425faba/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e04/10589876/89022a00b3d3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e04/10589876/e49b39f49477/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e04/10589876/910820426ef4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e04/10589876/7fdf4f1bade8/gr5.jpg

相似文献

1
Protocol for rapidly inducing genome-wide RNA Pol II hyperphosphorylation by selectively disrupting INTAC phosphatase activity.通过选择性破坏 INTAC 磷酸酶活性快速诱导全基因组 RNA Pol II 高度磷酸化的方案。
STAR Protoc. 2023 Dec 15;4(4):102640. doi: 10.1016/j.xpro.2023.102640. Epub 2023 Oct 12.
2
INTAC endonuclease and phosphatase modules differentially regulate transcription by RNA polymerase II.INTAC 内切酶和磷酸酶结构域通过 RNA 聚合酶 II 差异调控转录。
Mol Cell. 2023 May 18;83(10):1588-1604.e5. doi: 10.1016/j.molcel.2023.03.022. Epub 2023 Apr 19.
3
Protocol for the in vitro reconstruction of site-specifically phosphorylated RNA Pol II to identify the recruitment of novel transcription regulators.体外重建特定位点磷酸化 RNA 聚合酶 II 的方案,以鉴定新型转录调控因子的募集。
STAR Protoc. 2024 Sep 20;5(3):103277. doi: 10.1016/j.xpro.2024.103277. Epub 2024 Aug 27.
4
CRL3 ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription.CRL3泛素连接酶和整合酶磷酸酶形成平行机制来控制RNA聚合酶II转录的早期阶段。
Mol Cell. 2024 Dec 19;84(24):4808-4823.e13. doi: 10.1016/j.molcel.2024.11.024. Epub 2024 Dec 11.
5
SPT5 stabilizes RNA polymerase II, orchestrates transcription cycles, and maintains the enhancer landscape.SPT5 稳定 RNA 聚合酶 II,协调转录周期,并维持增强子景观。
Mol Cell. 2021 Nov 4;81(21):4425-4439.e6. doi: 10.1016/j.molcel.2021.08.029. Epub 2021 Sep 16.
6
Post-Translational Modification, Phase Separation, and Robust Gene Transcription.翻译后修饰、相分离和稳健的基因转录。
Trends Genet. 2019 Feb;35(2):89-92. doi: 10.1016/j.tig.2018.11.002. Epub 2018 Nov 23.
7
Protocol to detect spontaneous termination of yeast RNAPII transcription in vitro.体外检测酵母RNA聚合酶II转录自发终止的实验方案。
STAR Protoc. 2024 Dec 20;5(4):103369. doi: 10.1016/j.xpro.2024.103369. Epub 2024 Oct 10.
8
RPAP2 regulates a transcription initiation checkpoint by inhibiting assembly of pre-initiation complex.RPAP2 通过抑制起始前复合物的组装来调节转录起始检查点。
Cell Rep. 2022 Apr 26;39(4):110732. doi: 10.1016/j.celrep.2022.110732.
9
CDK9 and PP2A regulate RNA polymerase II transcription termination and coupled RNA maturation.CDK9 和 PP2A 调节 RNA 聚合酶 II 转录终止和偶联的 RNA 成熟。
EMBO Rep. 2022 Oct 6;23(10):e54520. doi: 10.15252/embr.202154520. Epub 2022 Aug 18.
10
Pol II phosphorylation regulates a switch between transcriptional and splicing condensates.Pol II 磷酸化调节转录和剪接凝聚物之间的转换。
Nature. 2019 Aug;572(7770):543-548. doi: 10.1038/s41586-019-1464-0. Epub 2019 Aug 7.

引用本文的文献

1
SOX2 drives esophageal squamous carcinoma by reprogramming lipid metabolism and histone acetylation landscape.SOX2通过重编程脂质代谢和组蛋白乙酰化格局来驱动食管鳞状细胞癌。
Nat Commun. 2025 Sep 2;16(1):8190. doi: 10.1038/s41467-025-63591-z.
2
DSS1 is required for proper Integrator-PP2A function.正确的整合酶 - 蛋白磷酸酶2A(Integrator-PP2A)功能需要DSS1。
Nat Commun. 2025 Jul 5;16(1):6206. doi: 10.1038/s41467-025-61257-4.
3
Catalytic-independent functions of the Integrator-PP2A complex (INTAC) confer sensitivity to BET inhibition.
整合酶 - 蛋白磷酸酶2A复合物(INTAC)的非催化功能赋予了对溴结构域和额外末端结构域(BET)抑制的敏感性。
Nat Chem Biol. 2025 Jan 14. doi: 10.1038/s41589-024-01807-x.